Trials / Completed
CompletedNCT05722132
Latinos Kick Buts: Mobile Engagement and Cessation Support for Latinos Who Smoke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,826 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
Latino Kick Buts (LKB) is a smoking cessation treatment program available to Strong Memorial Hospital patients who smoke. LKB encompasses two integrated components: (1) a 12-week text messaging counseling program with interactive capabilities and (2) pharmacotherapy support (provision of nicotine replacement therapy at no cost). LKB utilization among Latinos who smoke remains minimal. This study aims to identify the types of text messages more effective in enrolling Latinos who smoke, identified in the electronic medical record, into LKB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | One cycle | Message Design Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. |
| BEHAVIORAL | 4 cycles | Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. |
| BEHAVIORAL | 5 Dollar Incentive | Participants will receive 3 messages per cycle that contain information on how to enroll in a cessation program. The introductory message will mention that participants will receive $5 if they enroll in the program or that they should look out for messages with a "$" sign at the beginning that will provide an incentive if they respond. |
| BEHAVIORAL | Raffle Incentive | The incentive message (indicated with a leading "$" sign) will invite participants to respond, and participants that do so will be included in a random drawing depending on the condition. The incentive message for the opportunity to win will contain a link to a website that provides full details of the timing of the drawing, the chances of winning, and when notification of winners will be made. |
Timeline
- Start date
- 2022-12-27
- Primary completion
- 2023-03-25
- Completion
- 2023-03-25
- First posted
- 2023-02-10
- Last updated
- 2023-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05722132. Inclusion in this directory is not an endorsement.